Showing results (31-40 of 119) with videos related to
Sort By:
Pageof 12
Journal of Assisted Reproduction and Genetics|February 3, 2019
An integrated investigation of oocyte developmental competence: expression of key genes in human cumulus cells, morphokinetics of early divisions, blastulation, and euploidyC Scarica, D Cimadomo, L Dovere, et al.British Journal of Haematology|April 1, 1996
Correction of aplastic anaemia complicating paroxysmal nocturnal haemoglobinuria: absence of eradication of the PNH clone and dependence of response on cyclosporin A administrationA M Stoppa, N Vey, D Sainty, et al.British Journal of Haematology|August 1, 1989
Liquid culture and cryopreservation of marrow cells of leukaemic patients prior to autologous bone marrow transplantationA M Stoppa, D Maraninchi, M Lafage, et al.Bone Marrow Transplantation|May 1, 1994
Phase I study of in vivo lenograstim (rHuG-CSF) for stem cell collection demonstrates improved neutrophil recovery after autologous bone marrow transplantationA M Stoppa, D Blaise, P Viens, et al.Stem Cells (Dayton, Ohio)|May 1, 1994
In vivo stimulation of neutrophil function by lenograstim (glycosylated rHuG-CSF) in oncohematologic patients: results of a phase I trialC Fossat, A M Stoppa, D Sainty, et al.Blood|September 15, 1990
Hematologic and immunologic effects of the systemic administration of recombinant interleukin-2 after autologous bone marrow transplantationD Blaise, D Olive, A M Stoppa, et al.Reproductive Biomedicine Online|December 3, 2014
No evidence of association between blastocyst aneuploidy and morphokinetic assessment in a selected population of poor-prognosis patients: a longitudinal cohort studyL Rienzi, A Capalbo, M Stoppa, et al.Pathologie-Biologie|September 1, 1988
[Bacteremias after bone marrow grafts in a protected environment: effects, various aspects and prognosis]G Michel, D Maraninchi, D Blaise, et al.Leukemia|April 22, 2005
The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparisonM Mohty, H de Lavallade, P Ladaique, et al.Blood|November 1, 1991
High-dose recombinant interleukin-2 and acute myeloid leukemias in relapseD Maraninchi, D Blaise, P Viens, et al.Pageof 12